Improving a process to obtain hepatitis B serology among patients treated with infliximab at a large urban children’s hospital

BACKGROUND: Hepatitis B infection is a significant public health challenge despite improvements in vaccination efforts. Patients such as those on chronic immunosuppressive therapy for inflammatory bowel disease (IBD) or rheumatic disease may incur greater risk. The risk of reactivation of hepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales: Jean, M Raphaelle, Weaver, Ann, Mastin-Diebold, Teresa, Kissinger, Krista, Smitherman, Emily A, Favier, Leslie, Danziger-Isakov, Lara, Williams, Elizabeth, Brady, Rebecca C, Huggins, Jennifer, Denson, Lee A, Saeed, Shehzad A, Morgan, Pamela, Dykes, Dana Michelle Hines
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
BMJ Quality Improvement Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5699123/
https://www.ncbi.nlm.nih.gov/pubmed/29450279
http://dx.doi.org/10.1136/bmjoq-2017-000092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5699123/
https://www.ncbi.nlm.nih.gov/pubmed/29450279
http://dx.doi.org/10.1136/bmjoq-2017-000092

Ejemplares similares